rVWF IN PROPHYLAXIS

Clinical trial NCT02973087 · COMPLETED

Trial details

NCT number: NCT02973087
Sponsor: Takeda
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Von Willebrand Disease

Start date: 2017-11-16
Primary completion: 2020-07-06
Enrollment: 29

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.